Gül Dölen, an associate professor of neuroscience at Johns Hopkins University, explained to Analytical Cannabis just how MDMA-assisted psychotherapy can reopen a “critical period” in the brain for social reward learning.
Analytical Cannabis breaks down the traits and effects of the most commonly sought after psychedelic mushrooms.
Preclinical studies set to investigate the utility of a series of psychedelic-inspired drugs are now underway in Florida.
Elucidating the neural effects of psychedelics like LSD is helping to advance our understanding of the treatment strategies for a range of mental health illnesses.
The new open-label phase 2a trial will look at the use of an oral formulation of synthetic psilocybin and evaluate its safety and efficacy in a small number of patients with fibromyalgia.
The psychedelic drug psilocybin, a naturally occurring compound found in some mushrooms, has been shown to initiate an immediate and long-lasting increase in neural connections in mice.
The researchers also found that the drug increased the complexity of only certain brain states, known as segregated brain states.